Excelsior Correspondent
JAMMU, Mar 4: Apollo Hospitals, the nation’s foremost integrated healthcare provider today inked a landmark partnership with Ion Beam Applications (IBA), the global leader in Proton Beam Therapy (PBT) solutions, to introduce Proteus One system in India.
In this regard a Memorandum of Understanding was signed here today.
This event was officiated by Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd (AHEL) and Olivier Legrain, Chief Executive Officer, IBA, in the distinguished presence of Royal Princess Astrid of Belgium, Representative of King Philippe.
Speaking on the occasion, Dr Prathap C Reddy, Founder Chairman, Apollo Hospitals expressed his pride in Apollo’s pioneering spirit.
He said, “At Apollo, we are driven by an unyielding passion for excellence in healthcare. Our commitment is to ensure that India remains at the forefront of medical innovation, providing patients with access to the world’s most advanced treatments. The addition of Proteus One to our Apollo Proton Cancer Centres further solidifies our position as a global leader in Proton Therapy. This next-generation technology will allow us to achieve superior clinical outcomes and significantly improve the quality of life for cancer patients in India and beyond.”
Olivier Legrain said, “These contracts expand upon the close relationship we have built for more than a decade with Apollo Hospitals. Seeing an existing customer reaffirming its confidence in our solutions not only demonstrates the reliability and superiority of the IBA portfolio but also highlights the level of excellence of the services we deliver. We look forward to further strengthening our relationship with Apollo as we enable more patients in India to gain access to this life-saving treatment modality.”
Dr Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, highlighted the broader vision behind this collaboration.
She said, “Cancer care is evolving rapidly, and at Apollo, we remain steadfast in our mission to stay ahead of this evolution. The introduction of the Proteus One system is a significant leap towards personalized, precise, and highly effective treatment for cancer patients. Our partnership with IBA reflects our dedication to bringing new hope and healing to patients and families fighting cancer.”
According to the studies, the global burden of cancer is projected to increase to 21.4 million incident cases by 2030.
As per the study published in The Lancet Regional Health, worldwide in terms of absolute incidence number, following China and the US, India ranks third, contributing 7.5% of all new cancer incidences and is expected to grow to 1.5 million this year.
Follow our WhatsApp channel
